Shank Medicare

Manufacturing Intermediates for
Loratadine
a)8-Chloro-10,11-Dihydro-4Aza-5H-(a,d)Dibenzo-Cycloheptene-5One
b)2-Cyano-3-Methyl Pyridine
Enalapril Maleate
a) ECPP
Lisnopril/Benezapril/Ramipril
a) Ethyl-2-Oxophenyl Butyrate
Benezapril
a)3-Bromo-2,3,4,5-Tetrahydro-1H(1)Benzepine-2-One
Venlafaxine Hcl
a)1-[(1-Cyano)-1-(4-Methoxy Phenyl)Methyl]Cyclohexanol

Activity:

- Contract Manufacturing
- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- API / chemicals
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Allergy
- Cardiovascular
- Diabetes

Markets Covered

a. HeadQuarter: India

b. Continent(s) active: Europe , Far East

c. Countries active: Spain ,Germany, Japan

Corporate data:

Number of Employees: 15

Turnover:

Amount:	Year:	Currency:
0.5 m	2000	US Dollar

Year founded: 2000

Partners / Alliances: Promoters of the company are Management Graduates and from Pharma background with more than 20 years experience in Indian MNC's like Ranbaxy Laboratories Ltd.